Continuous glucose monitoring in pregnancies with type 1 diabetes: small increases in time-in-range improve maternal and perinatal outcomes
- 17 January 2024
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 231 (4) , 467.e1-467.e8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targetsThe Lancet Diabetes & Endocrinology, 2023
- Glycemic Control Trajectories and Risk of Perinatal Complications Among Individuals With Gestational DiabetesJAMA Network Open, 2022
- Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose MonitoringAmerican Journal of Perinatology, 2022
- Relationship Between Time-in-Range, HbA1c, and the Glucose Management Indicator in Pregnancies Complicated by Type 1 DiabetesDiabetes Technology & Therapeutics, 2021
- Continuous Glucose Monitoring Time-in-Range and HbA 1c Targets in Pregnant Women with Type 1 DiabetesDiabetes Technology & Therapeutics, 2021
- Association of Improved Periconception Hemoglobin A1c With Pregnancy Outcomes in Women With DiabetesJAMA Network Open, 2020
- Time trends in pregnancy-related outcomes among women with type 1 diabetes mellitus, 2004–2017Journal of Perinatology, 2020
- Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range mattersDiabetologia, 2019
- Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnanciesDiabetologia, 2019
- Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D ExchangeDiabetes Technology & Therapeutics, 2018